Pharming Group
(NASDAQ) PHAR
Pharming Group Financials at a Glance
Market Cap
$1.16B
Revenue (TTM)
$375.99M
Net Income (TTM)
$2.82M
EPS (TTM)
$0.03
P/E Ratio
456.82
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Price
$12.01
Volume
96,059.459
Open
$13.07
Price
$12.01
Volume
96,059.459
Open
$13.07
Previous Close
$12.00
Daily Range
$11.83 - $13.08
52-Week Range
$8.69 - $21.34
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Price
$12.01
Volume
96,059.459
Open
$13.07
Previous Close
$12.00
Daily Range
$11.83 - $13.08
52-Week Range
$8.69 - $21.34
PHAR News
PHAR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pharming Group
Industry
Biotechnology
Sector
Health CareCEO
Fabrice Chouraqui, MBA
Website
www.pharming.comHeadquarters
Leiden, 2333 CR, NL
PHAR Financials
Key Financial Metrics (TTM)
Gross Margin
88%
Operating Margin
6%
Net Income Margin
1%
Return on Equity
1%
Return on Capital
6%
Return on Assets
1%
Earnings Yield
0.22%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.16B
Shares Outstanding
70.63M
Volume
96.06K
Avg. Volume
18.65K
Financials (TTM)
Gross Profit
$331.56M
Operating Income
$19.37M
EBITDA
$30.62M
Operating Cash Flow
$50.07M
Capital Expenditure
$751.09K
Free Cash Flow
$49.31M
Cash & ST Invst.
$179.81M
Total Debt
$115.78M
Pharming Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$106.39M
+14.8%
Gross Profit
$85.31M
+6.0%
Gross Margin
80.19%
N/A
Market Cap
$1.16B
N/A
Market Cap/Employee
$2.87M
N/A
Employees
404
N/A
Net Income
$5.29M
+85.2%
EBITDA
$6.20B
+39598.0%
Quarterly Fundamentals
Net Cash
$64.03M
+15.2%
Accounts Receivable
$54.69M
+9.0%
Inventory
$64.88M
+16.4%
Long Term Debt
$107.07M
+1.9%
Short Term Debt
$8.71M
+21.1%
Return on Assets
0.57%
N/A
Return on Invested Capital
5.63%
N/A
Free Cash Flow
$7.12M
-22.6%
Operating Cash Flow
$7.39M
-20.8%